Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Íåâðîëîãèÿ è íåéðîõèðóðãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé íåâðîëîãîâ è íåéðîõèðóðãîâ

Ôîðóì äëÿ îáùåíèÿ âðà÷åé íåâðîëîãîâ è íåéðîõèðóðãîâ Ôîðóì ïðåäíàçíà÷åí äëÿ îáùåíèÿ âðà÷åé ìåæäó ñîáîé.

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 05.08.2011, 16:42
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ÈÌÕÎ - èíòåðåñíî: ìåäèöèíñêèå ññûëêè.

BMJ 2011; 342
Editorial


Autoimmune encephalitis



Treatable syndromes with characteristic clinical features

It is essential not to miss potentially treatable causes of new onset confusion or amnesia. Once toxic and metabolic causes have been excluded, infectious encephalitis must be considered and treated. However, the results of a recent surveillance study in the United Kingdom found that only 42% of patients with encephalitis had an identifiable infectious cause. 1 Even just a decade ago, the cause of encephalitis in those without an identifiable infection may well have remained obscure. There is now unequivocal evidence that specific autoantibodies directed against neuronal proteins crucial to the control of neurotransmission are responsible for a proportion (~8% in one series 1) of such cases.2 Importantly, these autoimmune encephalitides may be treatable with immunotherapy.345678

Antibodies against two targets, the voltage gated potassium channel (VGKC) complex and the N-methyl-D-aspartic acid (NMDA) receptor, have emerged as important causes—more than 100 related or relevant articles have been published in the past two years alone. These autoimmune encephalitides have distinctive clinical features and can be diagnosed by simple serological tests. Despite almost certainly being underdiagnosed, about 400 patients with clinically relevant raised VGKC complex or NMDA antibody titres have been …

[Full text of this article] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
MKMED îäîáðèë(à): interesting, however serologic test aren't that simple.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 06.08.2011, 02:15
Àâàòàð äëÿ MKMED
MKMED MKMED âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.05.2006
Ãîðîä: Óôà
Ñîîáùåíèé: 1,530
Ïîáëàãîäàðèëè 467 ðàç(à) çà 458 ñîîáùåíèé
MKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êñòàòè, ðàäèîëîãàì:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
FRSM îäîáðèë(à): Thank you. Fair exchange!
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 06.08.2011, 17:51
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,433
Ïîáëàãîäàðèëè 5,208 ðàç(à) çà 4,959 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
When LP Is Not Necessary to Detect Subarachnoid Bleed

CT performed within 6 hours of symptom onset in neurologically intact patients had 100% negative predictive value in this prospective multicenter study.

Standard teaching is that lumbar puncture (LP) is essential in patients with suspected subarachnoid hemorrhage (SAH) despite normal head computed tomography (CT) scans. Researchers prospectively enrolled 3132 consecutive neurologically intact patients older than 15 who underwent head CT with third-generation multislice scanners to evaluate nontraumatic acute headache or headache with syncope at 11 tertiary emergency departments in Canada from 2000 to 2009. LP was performed at the discretion of the treating physician. Experienced radiologists who were blinded to the study interpreted all CT scans. SAH was defined by subarachnoid blood on CT, aneurysm on cerebral angiography, or xanthochromia in cerebrospinal fluid.

Mean headache peak pain severity was 8.7 on a 0–10 scale. LP was performed in 49% of patients after negative CT scans. Overall, 240 patients (7.7%) were diagnosed with SAH. The sensitivity of head CT for SAH was 92.9%, and the negative predictive value (NPV) was 99.4%. Emergency physicians identified all but three cases of SAH; all three patients were scanned >6 hours after headache onset. Among 953 patients who were scanned within 6 hours of symptom onset, head CT had 100% sensitivity and 100% NPV. Follow-up at 1 and 6 months did not identify any cases of missed SAH.

Comment: Because subarachnoid blood diffuses and hemolyzes within hours, CT might not be able to distinguish cerebrospinal fluid from blood as time passes. Patients with histories that raise concern for SAH should be prioritized to undergo CT within 6 hours of symptom onset. If CT is performed with a modern scanner and is interpreted as negative for SAH by an experienced radiologist, LP is unnecessary, unless it is being performed to detect other causes of headache.

— Kristi L. Koenig, MD, FACEP

Published in Journal Watch Emergency Medicine August 5, 2011

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
FRSM îäîáðèë(à): Ìû ïðîâîäèì ÊÒ â òå÷åíèå ÷àñà ïîñëå ïîñòóïëåíèÿ ïîäîáíûõ ïàöèåíòîâ â á-öó.
MKMED îäîáðèë(à):
pavelf îäîáðèë(à):
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 03.10.2011, 11:47
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Îïóáëèêîâàí â Annals of Internal Medicine, 2011, vol.155, ¹6.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 22.10.2011, 18:25
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãàéäëàéí îò American Academy of Neurology

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
smolin îäîáðèë(à): Ñïàñèáî
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 08.01.2012, 17:17
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåñêîëüêî ãàéäîâ îò American Academy of Neurology

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Îïóáëèêîâàíî â Neurology. 2012;78:139-145.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Îïóáëèêîâàíî â Neurology. 2011;77:2128-2134.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 13.01.2012, 20:54
tambofff tambofff âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.11.2010
Ãîðîä: Òàìáîâ
Ñîîáùåíèé: 228
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 15 ðàç(à) çà 13 ñîîáùåíèé
tambofff ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 13.02.2012, 08:32
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðîñòåéøèé îïðîñíèê äëÿ âûÿâëåíèÿ ïðèçíàêîâ êîãíèòèâíîé äèñôóíêöèè êàê ðàííåãî ôàêòîðà ðèñêà ðàçâèòèÿ áîëåçíè Àëüöãåéìåðà, ïðåäëàãàþò àìåðèêàíñêèå èññëåäîâàòåëè

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 25.04.2012, 19:33
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
smolin îäîáðèë(à): Âîò òîëüêî ïðî÷èòàë ðàññûëêó ñ íîâîñòüþ, õîòåë çàïîñòèòü
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 05.05.2012, 10:54
Àâàòàð äëÿ cactus1972
cactus1972 cactus1972 âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 14.01.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,200
Ñêàçàë(à) ñïàñèáî: 54
Ïîáëàãîäàðèëè 355 ðàç(à) çà 331 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 9
cactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåcactus1972 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íîâûé ãàéäëàéí ÀÍÀ/ASA ïî âåäåíèþ íåòðàâìàòè÷åñêîãî ÑÀÊ

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ïîëîæåíèÿ, äîáàâëåííûå è/èëè îáíîâëåííûå ïî ñðàâíåíèþ ñ ïðåäûäóùåé âåðñèåé

Öèòàòà:
The 5 new class I (level B) recommendations are as follows:

-After any aneurysm repair, immediate cerebrovascular imaging is generally recommended to identify remnants or recurrence of the aneurysm that may require treatment.

-Digital subtraction angiography with 3-dimensional rotational angiography is indicated for detection of aneurysm in patients with aSAH (except when the aneurysm was previously diagnosed by noninvasive angiography) and for planning treatment (to determine whether an aneurysm is amenable to coiling or to expedite microsurgery).

-Between the time of aSAH symptom onset and aneurysm obliteration, blood pressure should be controlled with a titratable agent to balance the risk for stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure.

-In the absence of a "compelling" contraindication, patients who undergo coiling or clipping of a ruptured aneurysm should have delayed follow-up vascular imaging (timing and modality to be individualized), and re-treatment, by repeat coiling or clipping, should be strongly considered if there is a clinically significant (eg, growing) remnant.

-Heparin-induced thrombocytopenia and deep venous thrombosis are both infrequent but not uncommon occurrences after aSAH. Early identification and targeted treatment are recommended, but further research is needed to identify the ideal screening paradigms.

The 9 revised recommendations are as follows:

-For patients with an unfavorable delay in obliteration of aneurysm, a significant risk for rebleeding, and no compelling medical contraindications, short-term ( < 72 hours) therapy with tranexamic acid or aminocaproic acid is reasonable to reduce the risk for early aneurysm rebleeding. (Class IIa, Level B)

-Experienced cardiovascular surgeons and endovascular specialists should determine a multidisciplinary treatment approach based on characteristics of the patient and the aneurysm. (Class I, Level C)

-For patients with ruptured aneurysms judged to be technically amenable to both endovascular coiling and neurosurgical clipping, endovascular coiling should be considered. (Class I, Level B)

-Low-volume hospitals should consider early transfer of patients with aSAH to high-volume centers. (Class I, Level B)

-Maintaining euvolemia and normal circulating blood volume is recommended to prevent disseminated intravascular coagulation (DCI). (Revised, Class I, Level B)

-Induction of hypertension is recommended for patients with DCI unless blood pressure is elevated at baseline or cardiac status precludes it. (Class I, Level B)

-Cerebral angioplasty and/or selective intra-arterial vasodilator therapy is "reasonable" in patients with symptomatic cerebral vasospasm, particularly those who are not rapidly responding to hypertensive therapy. (Class IIa, Level B)

-aSAH-associated acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion (external ventricular drainage or lumbar drainage, depending on the clinical scenario). (Class I, Level B)

-aSAH-associated chronic symptomatic hydrocephalus should be treated with permanent cerebrospinal fluid diversion. (Class I, Level B)
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 27.06.2012, 12:21
nebel nebel âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.02.2007
Ãîðîä: Êðàñíîãîðñê
Ñîîáùåíèé: 6,240
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,966 ðàç(à) çà 1,915 ñîîáùåíèé
nebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñòàòüÿ èç CONTINUUMà ïî ýïèëåïòè÷åñêîìó ñòàòóñó :
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 17.08.2012, 22:48
smolin smolin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 24.05.2009
Ãîðîä: Éîøêàð-Îëà
Ñîîáùåíèé: 1,441
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 363 ðàç(à) çà 353 ñîîáùåíèé
smolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåsmolin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Âîò îíî êàê, îêàçûâàåòñÿ. Áåäíûå ìû áåäíûå. Ó êîãî ÷òî áîëèò, òîò î òîì è ãîâîðèò?

Öèòàòà:
Migraine Among Norwegian Neurologists

Background.— Previous studies have shown a high prevalence of migraine among neurologists. The main objective of this study was to assess the prevalence of migraine and its subtypes among neurologists in Norway.

Method.— Questionnaire-based cross-sectional study among every Norwegian neurologist registered on March 19, 2010.

Results.— Among the 384 neurologists, 245 (64%) participated. Of these, 95 (39%) reported having experienced migraine aura, and 86 having experienced migraine headache (35%). By employing the International Headache Society criteria for migraine with regard to the number of attacks, the gender-adjusted lifetime and 1-year prevalence was 38.7% (95% CI 30.3-47.7) and 33.8% (95% CI 25.9-47.2), respectively. Age-adjusted 1-year prevalence of migraine headache (not including subjects experiencing visual aura only) for men was 15.9% and for women 36.7%, which gives an overall age and gender-adjusted prevalence of 26.3% (95% CI 18.5-34.2). Solitary auras were experienced by 83 (34%), of which 73 (30%) had experienced this twice or more frequently. The majority of the neurologists thought that migraine was underdiagnosed and undertreated, 70% and 68%, respectively.

Conclusion.— The study confirms the results of previous studies, indicating that migraine, including visual aura, is more common among neurologists than what would be expected from population-based studies. Because this group, through professional experience with the condition, can make accurate diagnoses in themselves, and will have fewer problems with recalling headache episodes, the prevalence figures obtained may give the most precise estimate of the true population prevalence.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 22.08.2012, 11:48
nebel nebel âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.02.2007
Ãîðîä: Êðàñíîãîðñê
Ñîîáùåíèé: 6,240
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,966 ðàç(à) çà 1,915 ñîîáùåíèé
nebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Acute and Preventive Treatment of Migraine îïÿòü èç CONTINUUMa
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 18.09.2012, 16:31
nebel nebel âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.02.2007
Ãîðîä: Êðàñíîãîðñê
Ñîîáùåíèé: 6,240
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,966 ðàç(à) çà 1,915 ñîîáùåíèé
nebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûå êîëëåãè, åñòü áåñïëàòíûé äîñòóï ê ñòàòüÿì æóðíàëà "Clinical Practice Neurology" îò AAN, êàê äîëãî îíè áóäóò áåñïëàòíî äîñòóïíû ìíå íåèçâåñòíî, èìååò ñìûñë ïîòîðîïèòüñÿ ñî ñêà÷èâàíèåì.
ññûëêè ïðèâîæó íèæå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
Fahrenheit îäîáðèë(à):
__________________
Ñ óâàæåíèåì, Àíàñòàñèÿ Âàëåðüåâíà. Ìîé Instagram àêêàóíò @asarycheva
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 27.10.2012, 17:12
nebel nebel âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 27.02.2007
Ãîðîä: Êðàñíîãîðñê
Ñîîáùåíèé: 6,240
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,966 ðàç(à) çà 1,915 ñîîáùåíèé
nebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånebel ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Recurrent Spontaneous Attacks of Dizziness: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Ñ óâàæåíèåì, Àíàñòàñèÿ Âàëåðüåâíà. Ìîé Instagram àêêàóíò @asarycheva
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò


Îïöèè òåìû Ïîèñê â ýòîé òåìå
Ïîèñê â ýòîé òåìå:

Ðàñøèðåííûé ïîèñê
Îïöèè ïðîñìîòðà

Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 09:15.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.